The effect of monitoring of tobramycin levels in blood in patients with cystic fibrosis.
Completed
- Conditions
- Cystic fibrosis
- Registration Number
- NL-OMON20263
- Lead Sponsor
- AMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 35
Inclusion Criteria
Patients with cystic fibroses.
- Treatment with tobramycin
- Plasma concentration of tobramycine routinely measured
Exclusion Criteria
None
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method